Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 157   

Articles published

AZN 3,787.00 -22.50 (-0.59%)
price chart
Are Provident Financial plc and Rexam plc better income stocks than ...
One of the risks of investing in AstraZeneca (LSE: AZN) is the pharmaceutical patent cycle. In other words, AstraZeneca is still feeling the effects of the loss of patents for a number of key, blockbuster drugs from recent years and this is putting ...
The numbers don't lie, GlaxoSmithKline plc is set to beat AstraZeneca plc this ...
GlaxoSmithKline (LSE: GSK) has made a great start to 2016. The company's first-quarter results released at the end of last week, showed that Glaxo is on course to increase earnings by 10% to 12% this year, which is slightly ahead of market expectations.
Neil Woodford Buys Unloved NEXT plc, AstraZeneca plc And Capita PLC
High Street stalwart Next (LSE: NXT) has given shareholders the jitters in recent months, but the latest update from the CF Woodford Equity Income Fund explains why master investor Neil Woodford continues to believe in the company - and has averaged ...
AbbVie Inc, AstraZeneca plc, and Others: What's Next?
AstraZeneca plc (ADR) (NYSE:AZN) has a very robust drug portfolio along with a very supportive drug pipeline consisting of multiple molecules, which are undergoing different phases of clinical trials.
Time To Buy Pre-Referendum Bargains ARM Holdings plc, AstraZeneca plc & Marks ...
Whether the great British public votes 'in', 'out' or 'shake it all about' in June's EU referendum, the stock market is likely to breathe a sigh of relief that the build-up is all over.
Do The Risks Outweigh The Rewards For AstraZeneca plc, Ocado Group PLC And ...
For many investors, AstraZeneca (LSE: AZN) may appear to be a hugely risky stock. After all, it's currently in the midst of a patent cliff that's seeing multiple key, blockbuster drugs lose their patents.
Are ARM Holdings plc & AstraZeneca plc The FTSE 100's Best Growth Stocks?
The explosion in demand for smartphones, tablets and similar devices in recent years has seen ARM Holdings (LSE: ARM) emerge as one of the FTSE 100's most impressive growth selections.
Can AstraZeneca plc, Old Mutual Group plc And Standard Life Plc Turn Their ...
AstraZeneca is (quite rightly) pumping money into R&D, with core costs rising 21% in the last year, and all investors can do is hope it pays off, or risk losing their shirt.
AstraZeneca plc, SSE PLC & Legal & General Group Plc: Beautiful Bargains Or ...
To say that AstraZeneca (LSE: AZN) is a terrific bargain at current prices would be something of an understatement, in my opinion.
Summary of Analyst's Study: Merck & Company, Inc. (NYSE:MRK) , Astrazeneca PLC ...
Astrazeneca PLC (NYSE:AZN) after beginning at $29.11, closed at $29.28 by building up +1.10% in recent trading session. Most recent session's volume of 2.61 million shares lower than its average volume of 4.71 million shares.